Sfoglia per Rivista
TT virus infection in adult beta-thalassemia major patients
2001 M. Sampietro, D. Tavazzi, F. Martinez di Montemuros, M. Cerino, S. Zatelli, G. Lunghi, A. Orlandi, S. Fargion, G. Fiorelli, M.D. Cappellini
Two new alpha-globin gene cluster rearrangements causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients
2007 C. Refaldi, C. Harteveld, M.D. Cappellini, P.C. Giordano
Type 1 vs type 2 calreticulin mutations and thrombotic risk in essential thrombocythemia patients: analysis of a monocentric series
2015 A. Iurlo, D. Cattaneo, S. Fabris, M. Sciumè, N. Orofino, F. Guidotti, G. Ciceri, D. Giannarelli, U. Gianelli, L. Gugliotta, A. Neri, A. Cortelezzi
A type mutation II (Glu117stop), induction of allele-specific mRNA degradation and FXI deficiency
2005 G. Soldà, R. Asselta, R. Ghiotto, M. Malcovati, M.L. Tenchini, G. Castaman, S. Duga
Tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia: a retrospective analysis of 208 italian patients
2016 C. Fava, G. Rege-Cambrin, I. Dogliotti, P. Berchialla, E. Abruzzese, M. Annunziata, P. Avanzini, M. Bergamaschi, M. Bocchia, G. Caocci, G. Catania, D. Cattaneo, F. Cavazzini, M. Cerrano, E. Chiara, M. Crugnola, S. Galimberti, C. Gambacorti-Passerini, F. Iuliano, A. Iurlo, L. Levato, L. Luciano, P. Musto, E. Orlandi, P. Pregno, D. Rapezzi, S. Russo, M. Santoro, F. Sorà, M. Baccarani, D. Ferrero, G. Saglio
Tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia: a retrospective analysis of 208 italian patients
2017 C. Fava, G. Rege-Cambrin, I. Dogliotti, P. Berchialla, M. Cerrano, G. Rosti, F. Castagnetti, G. Gugliotta, B. Martino, C. Gambacorti-Passerini, E. Abruzzese, E. Orlandi, E. Chiara, P. Pregno, A. Gozzini, P. Avanzini, M. Bergamaschi, M. Crugnola, M. Bocchia, S. Galimberti, D. Rapezzi, A. Iurlo, D. Cattaneo, R. Latagliata, M. Breccia, M. Cedrone, M. Santoro, M. Annunziata, L. Levato, F. Stagno, F. Cavazzini, N. Sgherza, G. Catania, L. Luciano, S. Russo, P. Musto, G. Caocci, F. Sorà, F. Iuliano, F. Lunghi, G. Specchia, M. Baccarani, D. Ferrero, G. Saglio
Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia
2015 E. Brissot, M. Labopin, M. Beckers, G. Socie, A. Rambaldi, L. Volin, J. Finke, S. Lenhoff, N. Kroger, G. Ossenkoppele, C. Craddock, I. Yakoub Agha, G. Gurman, N. Russell, M. Aljurf, M. Potter, A. Nagler, O. Ottmann, J. Cornelissen, J. Esteve, M. Mohty
Understanding the contribute of the notch pathway in multiple myeloma bone marrowniche : a focus on extracellular vesicles-mediated communicatio
2017 M. Colombo, F. Baccianti, L. Cantone, A. Moschini, N. Platonova, S. Garavelli, M.T. Palano, R. Adami, A. Neri, V. Bollati, R. Chiaramonte
An unusual type of myeloid sarcoma localization following myelofibrosis
2017 N. Orofino, D. Cattaneo, C. Bucelli, L. Pettine, S. Fabris, U. Gianelli, N.S. Fracchiolla, A. Iurlo
Upfront treatment of mantle cell lymphoma by sequential high dose immunochemotherapy supported by in vivo-purged stem cell double autologous transplantation : a single institution experience
2010 G. Saporiti, F. Onida, A. Ferrario, D. Vincenti, C. Basilico, P. Usardi, F. Rossi, E. Tagliaferri, M. Goldaniga, C. Annaloro, L. Baldini, G. Lambertenghi Deliliers
Urate-oxidase : a new therapy of cytotoxic-drug-induced hyperuricemia
1981 P. Vigo, S. Ortolani, L. Soldati, R. Girardello, L. Fleischmann, E.E. Polli
Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy
1989 A. Gianni, M. Bregni, S. Siena, C. Tarella
Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies
2003 A. Nosari, M. Anghileri, G. Carrafiello, C. Guffanti, L. Marbello, M. Montillo, G. Muti, S. Ribera, A. Vanzulli, M. Nichelatti, E. Morra
Validation of a new prognostic index in patients with early chronic lymphocytic leukemia : the GIMEMA experience
2009 S. Molica, F.R. Mauro, V. Callea, D. Giannarelli, F. Lauria, B. Rotoli, M. Montanaro, A. Cortelezzi, V. Liso, R. Foà, T. GIMEMA CLL study group
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry
2000 C. Stelitano, L. Baldini, C. Pieresca, V. Callea, F. Angrilli, V. Clo, G. Partesotti, F. Merli, L. Cavanna, F. Morabito, M. Federico, M. Brugiatelli, V. Silingardi
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project
2018 B. Mora, T. Giorgino, P. Guglielmelli, E. Rumi, M. Maffioli, A. Rambaldi, M. Caramella, R. Komrokji, J. Gotlib, J. Kiladjian, F. Cervantes, T. Devos, F. Palandri, V. De Stefano, M. Ruggeri, R.T. Silver, G. Benevolo, F. Albano, C. Cavalloni, D. Barraco, M. Merli, D. Pietra, R. Casalone, T. Barbui, G. Rotunno, M. Cazzola, A.M. Vannucchi, F. Passamonti
The value of serum beta 2-microglobulin (beta-2M) in comparison with CD38 and ZAP-70 expression, and IGVH gene status in predicting therapy free interval in early B-cell chronic lymphocytic leukemia (B-CLL) patients
2007 F. Morabito, G. Cutrona, M. Gentile, V. Callea, C. Mazzone, M. Spriano, S. Matis, E. Rossi, G. Festini, A. Neri, S. Molica, M. Ferrarini
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions
2007 A.J. Ferreri, G.P. Dognini, E. Campo, R. Willemze, J.F. Seymour, O. Bairey, M. Martelli, A.O. De Renz, C. Doglioni, C. Montalbán, A. Tedeschi, A. Pavlovsky, S. Morgan, L.D. Uziel, M. Ferracci, S. Ascani, U. Gianelli, C. Patriarca, F. Facchetti, A. Dalla Libera, B. Pertoldi, B. Horváth, A. Szomor, E. Zucca, F. Cavalli, M. Ponzoni, I. Extranodal Lymphoma Study Group
Vascular fibrosis in stroke-prone rats (SHRSP) is prevented by drugs active on inflammatory pathways
2008 P. Gelosa, G. Sevin, C. Banfi, A. Pignieri, M. Brioschi, R. Ballerio, E. Tremoli, L. Sironi
Very eldery CP-CML patients treated with imatinib frontline: have concomitant therapies an impact on outcome and toxicity?
2015 A. Iurlo, R. Latagliata, C. Bucelli, D. Ferrero, F. Castagnetti, M. Breccia, E. Abruzzese, C. Fava, M. Annunziata, F. Stagno, P. Vigneri, M. Tiribelli, F. Cavazzini, G. Binotto, G. Mansueto, A. Gozzini, S. Russo, F. Falzetti, E. Montefusco, G. Gugliotta, D. Cattaneo, C.D. Djade, M. Cedrone, A. Russo Rossi, P. Avanzini, P. Pregno, E. Mauro, M. Endri, A. Spadea, F. Celesti, G. Giglio, A. Isidori, M. Crugnola, E. Calistri, F. Sorà, S. Sica, S. Storti, A. D’Addosio, G. Rege-Cambrin, L. Luciano, G. Saglio, G. Rosti, G. Alimena, A. Nobili, A. Cortelezzi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile